RecruitingNot ApplicableNCT06803446
Effects of Circadian Rhythm on Glycemic Regulation During Continuous Moderate Exercise and Intense Intermittent Disease in Adolescents Living With Type 1 Diabetes
Effets du Rythme Circadien Sur la régulation glycémique Lors d'Exercices modérés Continus et Intermittents Intenses Chez Des Adolescents Vivant Avec le diabète de Type 1
Sponsor
Lille University
Enrollment
18 participants
Start Date
Dec 18, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Interventional research with minimal risks and constraints on the effects of circadian rhythm on glycemic regulation during intense moderate, continuous and intermittent exercise in adolescents living with type 1 diabetes
Eligibility
Min Age: 10 YearsMax Age: 16 Years
Inclusion Criteria5
- Children and adolescents aged 10 to 16;
- Living with type 1 diabetes for at least 1 year with HbA1c less than or equal to 12%;
- Socially insured ;
- Having given their written consent to participate in the research, as well as that of their legal guardians;
- Willing to comply with all research procedures and duration.
Exclusion Criteria9
- Clinically significant microvascular complications: nephropathy (estimated glomerular filtration rate less than 40 ml/min), neuropathy or severe proliferative retinopathy as assessed by the investigator;
- Recent acute macrovascular event (\< 3 months), e.g. acute coronary syndrome or cardiac surgery;
- Abnormal blood picture and/or anemia;
- Current pregnancy;
- Other serious medical condition likely to interfere with study participation or ability to complete exercise periods in the judgment of the investigator (e.g., orthopedic limitation);
- Inability to receive informed information;
- Inability to participate in the entire study;
- Lack of social security coverage;
- Refusal to sign the consent form.
Interventions
OTHERphysical test
continuous and intermittent exercise on cycloergometer
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06803446
Related Trials
Safety, Pharmacokinetics, and Pharmacodynamics of MTX-101 in Healthy Adults and Patients
NCT063246044 locations
EMPoWER Study - Strengths-based Behavioral Intervention for Youth With Type 1 Diabetes
NCT060148791 location
Intervention for Children With Type 1 Diabetes Targeting Gut Microbes
NCT061987251 location
Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 Diabetes Using Automated Insulin Delivery
NCT072121791 location
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
NCT0706157411 locations